Maravai LifeSciences completed the acquisition of Alphazyme.

Synopsis

Maravai LifeSciences, a life sciences company providing critical products to enable the development of drug therapies, diagnostics, novel vaccines, completed the acquisition of Alphazyme, an OEM provider of custom, scalable molecular biology enzymes. Financial terms were not disclosed.

Principals

target

Alphazyme

bidder

Maravai Lifesciences

Show Details & Financials

Did you work on this deal?

Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.

Market Context

Sort

Seller Team (1)

christopher benoit

CEO at ALPHAZYME LLC

Manager

target

Deal

n/a

Total Value

Bidder Team (3)

carl hull

Chairman and CEO at MARAVAI LIFESCIENCES INC

Manager

bidder

Deals

£ 179 M

Total Value

justin sun

Rothschild & Co

Financial Advisor

bidder

Deals

n/a

Total Value

timothy hotchandani

Managing Director at Rothschild & Co

Financial Advisor

bidder

Deals

£ 4.65 B

Total Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy